Rutamarin is a natural compound primarily studied for its diverse biological activities in pharmaceutical research. It exhibits anti-inflammatory and analgesic properties, demonstrating potential in reducing pain and inflammation in preclinical models, which may support the development of natural therapeutic agents for chronic inflammatory conditions. The compound also shows antimicrobial activity against certain bacteria and fungi, suggesting possible applications in anti-infective formulations. Additionally, rutamarin has been investigated for its anti-cancer effects, inhibiting the growth of specific cancer cells in in vitro studies. It further modulates metabolic pathways, aligning with traditional uses in managing metabolic or cardiovascular conditions. Research remains predominantly experimental, focusing on pharmacological mechanisms, with further studies needed to validate efficacy and safety in humans.